Target intelligence / Profile preview

Biotinidase (BTD)

Target
BTD
Molecular classification
Enzyme, Hydrolase (specifically, carbon-nitrogen hydrolase, EC 3.5.1.12)
01

Overview

Biotinidase is an enzyme (EC 3.5.1.12) encoded by the BTD gene located on chromosome 3p25, responsible for cleaving biotin (vitamin H) from biocytin (biotinyl-lysine) and from biotin-bound peptides, thus recycling biotin for reuse as a cofactor by carboxylase enzymes involved in the metabolism of fats, carbohydrates, and proteins[1][5]. Its deficiency, inherited in an autosomal recessive manner, results in impaired biotin recycling, leading to multiple carboxylase deficiency with neurocutaneous and metabolic manifestations, but can be effectively treated and prevented by oral biotin supplementation[2][5]. The enzyme is a glycoprotein with multiple isoforms and glycosylation sites, exhibits a catalytic triad (glutamate, lysine, cysteine), and acts primarily in tissues with high metabolic demand including liver and brain[3][5]. Biotinidase deficiency is included in newborn screening programs due to the severity but treatability of disease upon early detection[5][7].

Other names
biotinaseamidohydrolase biotinidasebiotin-amide amidohydrolase
02

Mechanism of action

Biotin supplementation compensates for endogenous enzyme deficiency by providing free biotin that bypasses the need for biotin release by biotinidase

03

Biological functions

Biotin recyclingBiotin metabolismRelease of free biotin from food and proteinsSupport of carboxylase enzyme activity (metabolism of fats, carbohydrates, and proteins)
04

Disease associations

Inherited metabolic disorder (biotinidase deficiency)Neurocutaneous disorder
05

Safety considerations

Timely diagnosis required to prevent irreversible neurological damageno major drug-related safety issues, but lack of treatment leads to metabolic and neurological complications
06

Interacting drugs

Pharmacological biotin (therapeutic supplementation as rescue therapy for deficiency)
07

Biomarkers

Serum biotinidase activityMolecular genetic testing of BTD gene

Beyond the preview

Go deeper on Biotinidase (BTD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotinidase (BTD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call